Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Novartis Finland Oy
OY
Active
Y-tunnus 0113649-5
Revontulenkuja 1, 02100
Espoo
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1966
89 employees
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Novartis Finland Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
28M
56M
85M
113M
98M
2020
93M
2021
83M
2022
0M
2023
88M
2024
EBITDA
EUR millions
0M
1M
3M
4M
6M
4M
2020
5M
2021
3M
2022
0M
2023
5M
2024
Income statement
EUR thousands
Item
2020
2021
2022
2023
2024
Revenue
98 396
92 694
83 126
0
87 802
Staff expenses
−14 282
−15 097
−18 097
0
−12 294
EBITDA
3 673
4 501
3 291
−0
4 504
Depreciation & amort.
−104
−57
−182
−0
−75
EBIT
3 569
4 444
3 109
−0
4 429
Net financials
−22
−24
3
0
−16
Profit before tax
3 547
4 420
3 112
−0
4 412
Tax
779
854
1 055
−0
916
Net profit
2 768
3 566
2 057
0
3 496
Balance sheet
EUR thousands
Item
2020
2021
2022
2023
2024
Total assets
37 571
37 161
47 151
0
32 088
Equity
17 785
21 350
23 407
16 488
16 984
Long-term debt
1 257
1 001
947
0
0
Short-term debt
18 155
14 810
21 060
25 055
15 104
Total debt
19 787
15 811
23 744
25 055
15 104
Financial ratios
5-year trend
EBITDA margin
5.1%
This company
15.8%
Market median
-68% vs market
2020
2024
Equity ratio
52.9%
This company
38.2%
Market median
+38% vs market
2020
2024
Return on equity
20.6%
This company
18.4%
Market median
+12% vs market
2020
2024
Net profit margin
4.0%
This company
8.1%
Market median
-51% vs market
2020
2024
Asset turnover
2.74×
This company
1.12×
Market median
+145% vs market
2020
2024
Debt / equity
0.89×
This company
0.62×
Market median
+44% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
More on Novartis Finland Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
